Monovisc Solution For Injection 22Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Monovisc: Solution for injection (22mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

SODIUM HYALURONATE (SOE dee um hye al yoor ON ate) is used to treat pain in the knee due to osteoarthritis. It can also be used during eye surgery.

In-Depth Information

Monovisc 88mg/4ml Solution for Injection

NDC: 596760820
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)




FDA approved for the following conditions:
Osteoarthritis

Storage Information
Store in original package until time of use
Discard unused portion. Do not store for later use.
Do not freeze
Store below 77 degrees F
Monovisc 88mg/4ml Solution for Injection

Reported Side Effects for Monovisc 88mg/4ml Solution for Injection

Injection Site Reaction Incidence:
<23.0%*
Severity: MILD
Onset: RAPID
Skin Redness Incidence:
<0.7%*
Severity: MODERATE
Onset: EARLY
Loose Stools Incidence:
<4.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
<4.0%*
Severity: MILD
Onset: EARLY
Stomach Pain Incidence:
<4.0%*
Severity: MILD
Onset: EARLY
Joint Inflammation Incidence:
0.5%*
Severity: MODERATE
Onset: DELAYED
Back Pain Incidence:
0.6-11.5%*
Severity: MILD
Onset: DELAYED
Upset Stomach Incidence:
0.6-4.0%*
Severity: MILD
Onset: EARLY
Arthropathy Incidence:
0.7-11.0%*
Severity: MILD
Onset: DELAYED
Swelling Incidence:
0.9-13.0%*
Severity: MODERATE
Onset: DELAYED
Paresthesias Incidence:
1.2%*
Severity: MILD
Onset: DELAYED
Tired Incidence:
1.3-1.9%*
Severity: MILD
Onset: EARLY
Joint Pain Incidence:
1.3-17.8%*
Severity: MILD
Onset: DELAYED
Skin Rash Incidence:
3.0%*
Severity: MILD
Onset: EARLY
Stomach Ulcer Incidence:
3.0%*
Severity: SEVERE
Onset: DELAYED
Muscle And/Or Bone Pain Incidence:
3.0%*
Severity: MILD
Onset: EARLY
Weakness Incidence:
3.0%*
Severity: MILD
Onset: DELAYED
Angioedema Incidence:
3.0%*
Severity: SEVERE
Onset: RAPID
Headache Incidence:
3.4-18.0%*
Severity: MILD
Onset: EARLY
Itching Incidence:
7.0%*
Severity: MILD
Onset: RAPID
Bruise Incidence:
14.0%*
Severity: MILD
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Monovisc

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5